Quantitative immunolocalization of mu opioid receptors: Regulation by naltrexone

Neuroscience

Volumn 85, Issue 3, 1998, Pages 897-905

  Unterwald, E M ^a,b   Anton, B ^c   To, T ^c   Lam, H ^c   Evans, C J ^c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunohistochemistry; Mu opioid receptors; Naltrexone; Rat brain; Receptor autoradiography; Receptor upregulation

Indexed keywords

MU OPIATE RECEPTOR; NALTREXONE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN; DRUG RECEPTOR BINDING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; TISSUE DISTRIBUTION;

ANALGESICS, OPIOID; ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; TRITIUM; UP-REGULATION;

EID: 0031949981     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00659-3     Document Type: Article

References (40)

1. Arden J. R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1995;1636-1645.
2. Bard J., Vevy R., Simantov R. Up-regulation of opiate receptors by opiate antagonists in neuroblastoma-glioma cell culture: the possibility of interaction with guanosine triphosphate-binding proteins. Neurosci. Lett. 50:1984;133-137.
3. Belcheva M. M., Barg J., McHale R. J., Gao X. M., Chuang D. M., Coscia C. J. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone. J. Pharmac. exp. Ther. 259:1991;302-309.
4. Brunello N., Volterra A., DiGiulio A. M., Cuomo V., Racagni G. Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates. Life Sci. 34:1984;1669-1678.
5. Chen Y., Mestek A., Liu J., Hurley J. A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Molec. Pharmac. 44:1993;8-12.
6. Childers S. R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991;1191-2003.
7. Cote T. E., Izenwasser S., Weems H. B. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase. J. Pharmac. exp. Ther. 267:1993;238-244.
8. 353, located within the COOH-terminal tail of the d opiate receptor, is involved in receptor down-regulation. J. biol. Chem. 271:1996;4073-4076.
9. 5-enkephalin binding sites by different mechanisms. Neuropharmacology. 27:1988;965-974.
10. Fan L. Q., Gioannini T. L., Wolinisky T., Hiller J. M., Simon E. J. Functional reconstitution of a highly purified mu-opioid receptor protein with purified G proteins in liposomes. J. Neurochem. 65:1995;2537-2542.
11. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. Fedn Eur. biochem. Socs Lett. 327:1993;311-314.
12. Grady E. F., Garland A. M., Gamp P. D., Lovett M., Payan D. G., Bunnett N. W. Delineation of the endocytic pathwqy of substance P and its seven transmembrane domain NK1 receptor. Molec. Biol. Cell. 6:1995;509-524.
13. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., Brass L. F. Internalization and recycling of activated thrombin receptors. J. biol. Chem. 268:1993;13756-13763.
14. Jones E. G., Hendry S. H. C., Liu X.-B., Hodgins S., Potkin S. G., Tourtellotte W. W. A method for fixation of previously fresh-frozen human adult and fetal brains that perserves histological quality and immunoreactivity. J. Neurosci. Meth. 44:1992;133-144.
15. Keith D. E., Murray S. R., Zaki P. A., Chu P. C., Lissin D. V., Kang L., Evans C., von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. J. biol. Chem. 271:1996;19021-19024.
16. Lahti R., Collins R. Chronic naloxone results in prolonged increases in opiate binding sites in brain. Eur. J. Pharmac. 51:1978;185-186.
17. Mansour A., Fox C. A., Akil H., Watson S. J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications (review). Trends Neurosci. 18:1995;22-29.
18. Matthes H. W. D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., LeMeur M., Dolle P., Tzavara E., Hanoune J., Roques B. P., Kieffer B. L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
19. Millan M. J., Morris B. J., Herz A. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. J. Pharmac. exp. Ther. 247:1988;721-728.
20. Minami M., Onogi T., Toya T., Katao Y., Hosoi Y., Maekawa K., Katsumata S., Yabuuchi K., Satoh Molecular cloning and in situ hybridization histochemistry for rat μ-opioid receptor. Neurosci. Res. 18:1994;315-322.
21. Morris B. J., Millan M. J., Herz A. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta, and kappa binding sites in rat brain revealed by quantitative autoradiography. J. Pharmac. exp. Ther. 247:1988;729-736.
22. North R. A., Williams J. T., Surprenant A., Christie M. J. μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc. natn. Acad. Sci. U.S.A. 84:1987;5487-5491.
23. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Academic, New York.
24. Reisine T., Bell G. I. Molecular biology of opioid receptors (review). Trends Neurosci. 16:1993;506-510.
25. 5]enkephali n: further evidence for two μ-binding sites. Eur. J. Pharmac. 160:1989;71-82.
26. Schenk S., Naweiesniak E. Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation. Pharmac. Biochem. Behav. 22:1985;175-177.
27. Smart D., Smith G., Lambert D. G. μ-Opioid receptor stimulation of inositol (1,4,5)triphosphate formation via a pertussis toxin-sensitive G protein. J. Neurochem. 62:1994;1009-1014.
28. Sternini C., Spann M., Anton B., Keith D. E. Jr., Bunnett N. W., von Zastrow M., Evans C. E., Brecha N. C. Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. natn. Acad. Sci. U.S.A. 93:1996;9241-9246.
29. Tempel A., Crain S. M., Peterson E. R., Simon E. J., Zukin R. S. Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. Devl Brain Res. 25:1986;287-291.
30. Tempel A., Gardner E. L., Zukin R. S. Visualization of opiate receptor upregulation by light microscopy autoradiography. Proc. natn. Acad. Sci. U.S.A. 81:1984;3893-3897.
31. Tempel A., Gardner E. L., Zukin R. S. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J. Pharmac. exp. Ther. 232:1985;439-444.
32. Thompson R. C., Mansour A., Akil H., Watson S. J. Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron. 11:1993;903-913.
33. Trapaidze N., Keith D. E., Cvejic S., Evans C. J., Devi L. A. Sequestration of the δ opioid receptor; role of the C terminus in agonist-mediated internalization. J. biol. Chem. 271:1996;19279-19285.
34. Unterwald E. M., Rubenfeld J. M., Imai Y., Wang J. B., Uhl G. R., Kreek M. J. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Molec. Brain Res. 33:1995;351-355.
35. von Zastrow M., Kobilka B. K. Ligand-regulated internalization and recycling of human β2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. biol. Chem. 267:1992;3530-3538.
36. Wang J. B., Imai Y., Eppler C. M., Gregor P., Spivak C. E., Uhl G. R. μ opiate receptor: cDNA cloning and expression. Proc. natn. Acad. Sci. U.S.A. 90:1993;10230-10234.
37. Yoburn B. C., Goodman R. R., Cohen A. H., Pasternak G. W., Inturrisi C. E. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sci. 36:1985;2325-2332.
38. Yoburn B. C., Nunes F. S., Adler B., Pasternak G. W., Inturrisi C. E. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse. J. Pharmac. exp. Ther. 239:1986;132-135.
39. Zimprich A., Simon T., Hollt V. Cloning and expression of an isoform of the rat m opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. Fedn Eur. biochem. Socs Lett. 359:1995;142-146.
40. Zukin R. S., Sugarman J. R., Fitz-Syage M. L., Gardner E. L., Zukin S. R., Gintzler A. R. Naltrexone-induced opiate receptor supersensitivity. Brain Res. 245:1982;285-292.